BFC Planning’s Dogwood Therapeutics DWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27 Hold
20
– – ﹤0.01% 3437
2026
Q2
$32 Hold
20
– – ﹤0.01% 3387
2026
Q1
$42 Hold
20
– – ﹤0.01% 2992
2025
Q4
$83 Sell
20
-20
-50% -$118 ﹤0.01% 3105
2025
Q3
$308 Hold
40
– – ﹤0.01% 2795
2025
Q2
$191 Hold
40
– – ﹤0.01% 2607
2025
Q1
$200 Hold
40
– – ﹤0.01% 2585
2024
Q4
$100 Sell
40
-20
-33% -$66 ﹤0.01% 2543
2024
Q3
$255 Buy
+60
New +$311 ﹤0.01% 2509

Other funds holding DWTX

BFC Planning's DWTX Position: Q3 2026 in Review

BFC Planning held its Dogwood Therapeutics (DWTX) position steady in Q3 2026 at 20 shares worth $27. The position accounts for ﹤0.01% of the portfolio, ranked #3437.

BFC Planning first reported a position in DWTX in Q3 2024 and has held it in 9 quarters since. The position peaked at $308 in Q3 2025. 15 funds tracked by Wall St. Rank hold DWTX as of Q3 2026.

  • BFC Planning held 20 shares of Dogwood Therapeutics worth $27 as of Q3 2026.
  • BFC Planning left its Dogwood Therapeutics share count unchanged in Q3 2026.
  • Dogwood Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3437 holding.
  • BFC Planning first reported a position in Dogwood Therapeutics in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's Dogwood Therapeutics position peaked at $308 in Q3 2025.
  • 15 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.